Back
Mobileye Global 10K Form
Sell
47
MBLY
Mobileye Global
Last Price:
28.57
Seasonality Move:
0.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-09 | 10Q | MBLY/Mobileye Global Quarterly |
| 2023-08-10 | 10Q | MBLY/Mobileye Global Quarterly |
| 2023-05-11 | 10Q | MBLY/Mobileye Global Quarterly |
| 2022-12-07 | 10Q | MBLY/Mobileye Global Quarterly |
Receive MBLY News And Ratings
See the #1 stock for the next 7 days that we like better than MBLY
MBLY Financial Statistics
Sales & Book Value
| Annual Sales: | $2.08B |
|---|---|
| Cash Flow: | $18M |
| Price / Cash Flow: | 136.52 |
| Annual Sales: | $18.31 |
| Price / Book: | 1.56 |
Profitability
| EPS (TTM): | -0.21000 |
|---|---|
| Net Income (TTM): | $-166M |
| Gross Margin: | $1.05B |
| Return on Equity: | -1.12% |
| Return on Assets: | -1.07% |
Mobileye Global Earnings Forecast
Key Mobileye Global Financial Ratios
- The Gross Profit Margin over the past 9 years for MBLY is 50.36%.
- The Selling, General & Administrative Expenses for MBLY have been equal to 9.19% of Gross Profit Margin.
- The Research & Development expenses have been 42.76% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of MBLY is -1.30% of Total Revenues.
- Per Share Earnings over the last 9 years have been positive in 6 years.
Mobileye Global Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Automobile Components |
| Sector: | Consumer Discretionary |
| Current Symbol: | MBLY |
| CUSIP: | N51488 |
| Website: | mobileye.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.87 |
| Quick Ratio: | 4.08 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 36.23 |
MBLY Technical Analysis vs Fundamental Analysis
Sell
47
Mobileye Global (MBLY)
is a Sell
Is Mobileye Global a Buy or a Sell?
-
Mobileye Global stock is rated a Sell
The current Mobileye Global [MBLY] share price is $28.58. The Score for MBLY is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.